Allogeneic BM transplantation for the treatment of aplastic anemia: current results and expanding donor possibilities

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2013, Issue , 2013, Pages 82-86

  Socié, Gérard ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ALLOGRAFT; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; DISEASE FREE SURVIVAL; GRAFT VS HOST DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MORTALITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROCEDURES; SIBLING; SURVIVAL RATE; UNRELATED DONORS;

ADULT; AGE FACTORS; ALLOGRAFTS; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SIBLINGS; SURVIVAL RATE; UNRELATED DONORS;

EID: 84888261940     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2013.1.82     Document Type: Review

References (0)